Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-003567-21Phase 2Completed
Phase 2, randomised, single-blind trial comparing Prednisolone + inflammatory challenge with Vehicle control + inflammatory challenge (2 arms). Primary endpoint: Tolerability / safety endpoints. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-003567-21.